Reaffirming revenue guidance, especially in a range that indicates growth, is typically viewed positively by investors as it reflects management's confidence in the company's operational and financial strategies. For Biodesix, maintaining its revenue outlook for 2024 suggests that the company is on track to meet its financial targets, which could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.